These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10894464)

  • 1. Assessment end points for inhaled drug delivery.
    Anderson PJ
    Respir Care; 2000 Jun; 45(6):737-55. PubMed ID: 10894464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing inhaled corticosteroids.
    Colice GL
    Respir Care; 2000 Jul; 45(7):846-53. PubMed ID: 10926382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaler and spacer use in obstructive airway diseases.
    Jones MD; Yeager H
    Am Fam Physician; 1990 Oct; 42(4):1007-13. PubMed ID: 2220509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation.
    Miller DD; Amin MM; Palmer LB; Shah AR; Smaldone GC
    Am J Respir Crit Care Med; 2003 Nov; 168(10):1205-9. PubMed ID: 12893644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled bronchodilator administration during mechanical ventilation: how to optimize it, and for which clinical benefit?
    Guerin C; Fassier T; Bayle F; Lemasson S; Richard JC
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):85-96. PubMed ID: 18518835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations.
    Zeman KL; Wu J; Bennett WD
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):363-9. PubMed ID: 20863250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological perspectives of inhaled therapeutics and nanoparticles.
    Hayes AJ; Bakand S
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):933-47. PubMed ID: 24810077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special problems in aerosol delivery: neonatal and pediatric considerations.
    Cole CH
    Respir Care; 2000 Jun; 45(6):646-51. PubMed ID: 10894457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of deposition of inhaled aerosol in the respiratory tract of man using three-dimensional multimodality imaging and mathematical modeling.
    Fleming JS; Hashish AH; Conway JH; Nassim MA; Holgate ST; Halson P; Moore E; Bailey AG; Martonen TB
    J Aerosol Med; 1996; 9(3):317-27. PubMed ID: 10163661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalable drugs for systemic therapy.
    Corkery K
    Respir Care; 2000 Jul; 45(7):831-5. PubMed ID: 10926380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects.
    Newman SP; Newhouse MT
    J Aerosol Med; 1996; 9(1):55-70. PubMed ID: 10160209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
    Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
    Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aerosol therapy in obstructive respiratory tract diseases: deposition, administration methods, inhalation technics, inhalation aids].
    Niggemann B
    Ergeb Inn Med Kinderheilkd; 1989; 59():169-212. PubMed ID: 2686974
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in inhaled technologies: understanding the therapeutic challenge, predicting clinical performance, and designing the optimal inhaled product.
    Bäckman P; Adelmann H; Petersson G; Jones CB
    Clin Pharmacol Ther; 2014 May; 95(5):509-20. PubMed ID: 24503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized aerosol delivery to a mechanically ventilated rodent.
    MacLoughlin RJ; Higgins BD; Laffey JG; O'Brien T
    J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):323-32. PubMed ID: 19415985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled respiratory medications and the use of chlorofluorocarbons (CFCs). Thoracic Society of Australia and New Zealand.
    Pierce RJ; Seale JP; Ruffin RE
    Med J Aust; 1991 May; 154(10):701-4. PubMed ID: 2034155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of inhalation of a glucocorticoid using metered-dose propellant gas aerosol and Turbohaler--a roentgen pilot study].
    Vogel H; Wettmarshausen C
    Pneumologie; 1995 Oct; 49(10):559-60. PubMed ID: 8584527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.